A day after the House passed a bill that would protect Americans’ right to contraceptives, biotech execs say they will keep fighting for better access to novel birth control products.
The big question now is whether the legislation will survive the Senate floor.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,